Craft

Advanced
BioSenic

BioSenic

Stock Price

€0.1

2022-12-28

Market Capitalization

€6.2 M

2022-12-28

BioSenic Summary

Company Summary

Overview
BioSenic (formerly known as Bone Therapeutics) is a biotechnology company specializing in the treatment of osteo-articular diseases using cell therapy.
Type
Public
Status
Active
Founded
2006
HQ
Charleroi, BE | view all locations
Website
https://www.biosenic.com/home
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Gloria Matthews, Independent Director

    • Miguel Forte

      Miguel Forte, Chief Executive Officer, Director

      • Jean Stéphenne, Chairman

        • Jean-Paul Prieels, Independent Director

          LocationsView all

          2 locations detected

          • Charleroi, Wallonie HQ

            Belgium

            37 Rue Auguste Piccard

          • Charleroi, Wallonie

            Belgium

            Rue Adrienne Bolland 8

          BioSenic Financials

          Summary Financials

          Gross profit (H1, 2025)
          €1.0K
          Net income (H1, 2025)
          (€712.0K)
          Cash (H1, 2025)
          €501.0K
          EBIT (H1, 2025)
          (€410.0K)
          Enterprise value
          $29.2M

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX